The Chemours Company
CC
$12.79
$0.322.57%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.50B | 1.62B | 1.37B | 1.39B | 1.51B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.50B | 1.62B | 1.37B | 1.39B | 1.51B |
| Cost of Revenue | 1.26B | 1.34B | 1.13B | 1.12B | 1.22B |
| Gross Profit | 235.00M | 278.00M | 236.00M | 273.00M | 286.00M |
| SG&A Expenses | 105.00M | 178.00M | 121.00M | 199.00M | 135.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.39B | 1.54B | 1.28B | 1.35B | 1.39B |
| Operating Income | 104.00M | 72.00M | 88.00M | 48.00M | 122.00M |
| Income Before Tax | 51.00M | -261.00M | 0.00 | 9.00M | -32.00M |
| Income Tax Expenses | -9.00M | 119.00M | 4.00M | 17.00M | -- |
| Earnings from Continuing Operations | 60.00M | -380.00M | -4.00M | -8.00M | -32.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -1.00M | -- | -- | -- |
| Net Income | 60.00M | -381.00M | -4.00M | -8.00M | -32.00M |
| EBIT | 104.00M | 72.00M | 88.00M | 48.00M | 122.00M |
| EBITDA | 183.00M | 152.00M | 165.00M | 126.00M | 195.00M |
| EPS Basic | 0.40 | -2.54 | -0.03 | -0.05 | -0.21 |
| Normalized Basic EPS | 0.21 | 0.05 | 0.13 | -0.03 | 0.29 |
| EPS Diluted | 0.40 | -2.54 | -0.03 | -0.06 | -0.22 |
| Normalized Diluted EPS | 0.21 | 0.05 | 0.13 | -0.03 | 0.29 |
| Average Basic Shares Outstanding | 150.32M | 150.24M | 149.92M | 149.83M | 149.70M |
| Average Diluted Shares Outstanding | 150.78M | 150.24M | 149.92M | 149.83M | 149.70M |
| Dividend Per Share | 0.09 | 0.09 | 0.25 | 0.25 | 0.25 |
| Payout Ratio | 21.67% | -3.41% | -925.00% | -450.00% | -118.75% |